Millennium Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-500,000
Closed -$180K 4356
2017
Q3
$180K Hold
500,000
﹤0.01% 3272
2017
Q2
$190K Hold
500,000
﹤0.01% 3210
2017
Q1
$225K Sell
500,000
-250,000
-33% -$110K ﹤0.01% 3165
2016
Q4
$285K Sell
750,000
-750,000
-50% -$254K ﹤0.01% 2929
2016
Q3
$405K Buy
1,500,000
+2,600
+0.2% +$659 ﹤0.01% 2695
2016
Q2
$359K Sell
1,497,400
-2,600
-0.2% -$447 ﹤0.01% 2652
2016
Q1
$171K Hold
1,500,000
﹤0.01% 2995
2015
Q4
$169K Buy
1,500,000
+500,000
+50% +$70.6K ﹤0.01% 3156
2015
Q3
$190K Sell
1,000,000
-120,577
-11% -$41K ﹤0.01% 3133
2015
Q2
$784K Sell
1,120,577
-205,300
-15% -$142K ﹤0.01% 2398
2015
Q1
$899K Sell
1,325,877
-232,929
-15% -$163K ﹤0.01% 2385
2014
Q4
$1.23M Sell
1,558,806
-16,600
-1% -$11.3K ﹤0.01% 2346
2014
Q3
$733K Buy
1,575,406
+38,200
+2% +$18.5K ﹤0.01% 2502
2014
Q2
$769K Sell
1,537,206
-1,306,914
-46% -$632K ﹤0.01% 2341
2014
Q1
$882K Buy
2,844,120
+777,120
+38% +$289K ﹤0.01% 2297
2013
Q4
$703K Buy
2,067,000
+1,267,100
+158% +$1.53M ﹤0.01% 2507
2013
Q3
$1.62M Sell
799,900
-114,244
-12% -$218K 0.01% 1818
2013
Q2
$1.74M Buy
+914,144
New +$1.61M 0.01% 1674

Other funds holding GCVRZ

Millennium Management's GCVRZ Position: Q4 2017 in Review

Millennium Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2017, closing a stake of 500,000 shares — an estimated $180K sold.

Millennium Management first reported a position in GCVRZ in Q2 2013 and held it in 18 quarters. The position peaked at $1.74M in Q2 2013. 105 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2017.

  • Millennium Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2017 after selling out during the quarter.
  • Millennium Management sold 500,000 Sanofi Contingent Value Rights shares in Q4 2017, an estimated $180K.
  • Millennium Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 18 quarters.
  • Millennium Management's Sanofi Contingent Value Rights position peaked at $1.74M in Q2 2013.
  • 105 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2017.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.